欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33873 篇 当前为第 168 页 共 3388

所属行业:医药制造业

  • 1671.全球牙科车针和牙髓市场报告(2021-2028年)

    [医药制造业] [2022-02-27]

    Dental burs are medical devices used in modern dentistry for surgical care and tooth restoration procedure. These are designed as a powdered rotatory instrument such as tiny drilling equipment which is equipped with cutting blades on its edges. These are used to cut hard tissues such as bone and teeth. Endodontic is the study of science related to the soft tissue surrounding the root of a tooth and dental pulp. Endodontic includes endodontic retreatment, root canal treatment, dental implants, and endodontic surgery. This study comprises products only and not services. The study estimates the revenue generated from the sales of dental burs and endodontic. The valuations comprise revenue generated from the adoption of root canal procedures by patients. The study scope focuses on dental burs and endodontic products from e-commerce websites and pharmacies. Furthermore, the report excludes revenue generated from post-sale services of dental burs and endodontic products

    关键词:牙科车针;外科护理;牙齿修复程序;医疗设备;粉末旋转仪器;边缘切割刀片;牙髓再治疗;根管治疗;种植牙;牙髓手术
  • 1672.全球行为健康管理增长机会的数字健康解决方案

    [信息传输、软件和信息技术服务业,医药制造业] [2022-02-27]

    This study evaluates the market for digital tools for the management of behavioral health conditions, that is, behavioral health tech. The conditions included are listed below, and they are in keeping with NAMI’s definition of mental illness

    关键词:管理行为健康状况;数字工具市场;行为健康技术;NAMI ;精神疾病
  • 1673.全球限制肽药物市场分析与预测(2023-2031年)

    [医药制造业] [2022-02-26]

    Peptides are a selective, efficacious, and unique class of molecules that bind to specific cell surface receptors, triggering intracellular effects. They are short chains of amino acids linked by a peptide bond. Although they are molecularly poised between small molecules and proteins, peptides have distinctive therapeutic and biochemical properties. They represent an attractive first step in developing novel therapeutics across different areas, including oncology, metabolic, cardiovascular, infectious, endocrine, neurology, and other disorders. For decades, researchers have endeavored to comprehend intracellular protein-protein interactions (PPIs) as they play a critical role in the pathogenesis of numerous disease states. The development of constrained peptides exhibits an emerging approach that addresses challenging PPIs.

    关键词:肽;有效和独特;细胞表面受体结合;细胞内效应;短链氨基酸;小分子和蛋白质;生化性质;开发新疗法
  • 1674.全球数字健康市场(2021-2030年)

    [信息传输、软件和信息技术服务业,医药制造业] [2022-02-26]

    Digital health is an emerging technology, which uses connectivity, software, computing platforms, and sensors to enhance the quality of healthcare and its outcome. It increases the physical and emotional well-being of the population. This study comprises products only and not services. The study estimates the revenue generated from the sales of digital devices used for health care. The valuations comprise revenue generated from adoption of health, health information technology, wearable patch, telehealth and telemedicine by patients. The study scope focuses on digital health products for quality health care.

    关键词:数字健康;新兴技术;连接软件;计算平台;传感器;医疗保健;情绪健康;数字设备
  • 1675.全球牙耗材市场报告(2021-2028年)

    [医药制造业,化学纤维制造业] [2022-02-26]

    Endodontics is the study of science related to soft tissue surrounding the root of a tooth and dental pulp. Endodontics include endodontic retreatment, root canal treatment, dental implants and endodontic surgery. This study comprises products only and not the services. The study estimates the revenue generated from the sales of endodontic consumables. The valuations comprise revenue generated from the adoption of root canal procedures by patients. The study scope focuses on endodontics consumables for dental clinics and hospital and dental clinics. Furthermore, the report excludes revenue generated from post-sale services of endodontic consumables.

    关键词:牙髓病学;牙根和牙髓周围;软组织相关;牙髓再治疗;根管治疗;种植牙;牙髓手术
  • 1676.医疗保健行业:由UVL名单引发的思考,中国医药先进制造会回流吗?

    [医药制造业] [2022-02-24]

    细分行业短期面临挑战,但回流可能性较小。美国虽然正在重新思考他们的供应链战略,但事实上全球的供应链正在不断地融合,形成相互联系的庞大网络。重新建立供应链和生态体系需要付出大量的时间和资金成本,考虑到新冠疫情后美国政府财政压力增大,我们认为医药先进制造回流的概率相对较小。


    关键词:UVL;医药;制剂出口
  • 1677.创新药行业:中国创新药企迎来首个ODAC,国际化展翅在即-创新升级专题系列

    [医药制造业] [2022-02-23]

    创新才是生产力进步本质驱动;只有创新迭出的行业,才能有翻数倍成长的个股;同时,不论是医药还是其他科技行业的成长,不会因为上游供应链的区域阻断而停滞。

    关键词:医药板块;创新药;ODAC会议;国际化
  • 1678.2022年药品集采方向确定

    [医药制造业,卫生和社会工作] [2022-02-21]

    关键词:药品集采;
  • 1679.医药行业:CDMO性价比加速回归,值得长期坚定持有-CXO行业1月月报

    [医药制造业] [2022-02-17]

    新冠订单为短期业绩助推器,实则中国CDMO企业全球话语权提升。市场普遍认为新冠口服药带来的大额合同 订单为一过性影响因素,不仅不能因其带来的高业绩增速匹配高估值,同时新冠订单占据部分产能,可能会对非新冠项目 形成产能挤兑,因而,在陆续披露大订单后,相关CDMO企业股价出现回调现象。但是,我们认为,后疫情时代的新冠口 服药订单其实吹响产业升级的号角,中国CDMO企业被海外大药企纳入创新药商业化供应的第一梯队名单。中国化药 CDMO企业大都在2000年左右成立,早期处于拓市场、建口碑时期,多以接附加值较低的中间体或原料药订单为主,以 海外产业链转移为行业增长逻辑。历经20余年的发展,我们认为站在当下,中国化药CDMO企业的成长逻辑已转变成产 业升级,不再是低附加值的CMO订单转移,而是运用核心技术主导工艺开发的高附加值CDMO订单。

    关键词:医药行业;CDMO性价比;CXO行业
  • 1680.医药生物行业:《“十四五“医药工业发展规划》发布-双周报2022年第3期总第52期

    [医药制造业] [2022-02-17]

    本报告期医药生物行业指数跌幅为13.54%,表现不佳,在申万31 个一级行业中位居第31,跑输沪深300 指数(-3.45%)。从子行 业来看,医药生物三级行业全线下跌,其他生物制品、体外诊断、 医疗耗材板块跌幅居前,跌幅分别为22.05%、19.99%、18.05%。 估值方面,截止2022 年1 月28 日,医药生物行业PE(TTM 整体 法,剔除负值)为28.91x(上期33.48x),低于均值减一倍标准 差。医药生物申万三级行业原料药、化学制剂、中药、血液制品、 疫苗、其他生物制品、医药流通、线下药店、医疗设备、医疗耗 材、体外诊断、诊断服务、医疗研发外包、医院、其他医疗服务 PE(TTM 整体法,剔除负值)分别为34.20x、29.14x、29.01x、 34.09x、28.41x、25.79x、11.68x、28.61x、42.33x、16.64x、18.93x、 18.61x、64.40x、65.24x、87.10x。

    关键词:医药生物行业;医药工业;发展规划
首页  上一页  ...  163  164  165  166  167  168  169  170  171  172  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服